rs8178046

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006904.7(PRKDC):​c.2083C>T​(p.Pro695Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0147 in 1,579,236 control chromosomes in the GnomAD database, including 249 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 18 hom., cov: 32)
Exomes 𝑓: 0.015 ( 231 hom. )

Consequence

PRKDC
NM_006904.7 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.962

Publications

17 publications found
Variant links:
Genes affected
PRKDC (HGNC:9413): (protein kinase, DNA-activated, catalytic subunit) This gene encodes the catalytic subunit of the DNA-dependent protein kinase (DNA-PK). It functions with the Ku70/Ku80 heterodimer protein in DNA double strand break repair and recombination. The protein encoded is a member of the PI3/PI4-kinase family.[provided by RefSeq, Jul 2010]
PRKDC Gene-Disease associations (from GenCC):
  • severe combined immunodeficiency due to DNA-PKcs deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030925572).
BP6
Variant 8-47929148-G-A is Benign according to our data. Variant chr8-47929148-G-A is described in ClinVar as Benign. ClinVar VariationId is 379426.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0112 (1713/152292) while in subpopulation NFE AF = 0.0194 (1323/68024). AF 95% confidence interval is 0.0186. There are 18 homozygotes in GnomAd4. There are 767 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 18 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRKDCNM_006904.7 linkc.2083C>T p.Pro695Ser missense_variant Exon 19 of 86 ENST00000314191.7 NP_008835.5
PRKDCNM_001081640.2 linkc.2083C>T p.Pro695Ser missense_variant Exon 19 of 85 NP_001075109.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRKDCENST00000314191.7 linkc.2083C>T p.Pro695Ser missense_variant Exon 19 of 86 1 NM_006904.7 ENSP00000313420.3
PRKDCENST00000338368.7 linkc.2083C>T p.Pro695Ser missense_variant Exon 19 of 85 1 ENSP00000345182.4
PRKDCENST00000541488.1 linkn.22C>T non_coding_transcript_exon_variant Exon 1 of 3 3

Frequencies

GnomAD3 genomes
AF:
0.0113
AC:
1717
AN:
152174
Hom.:
18
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00278
Gnomad AMI
AF:
0.0559
Gnomad AMR
AF:
0.00753
Gnomad ASJ
AF:
0.0101
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00462
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0195
Gnomad OTH
AF:
0.0100
GnomAD2 exomes
AF:
0.00980
AC:
1956
AN:
199624
AF XY:
0.00918
show subpopulations
Gnomad AFR exome
AF:
0.00352
Gnomad AMR exome
AF:
0.00455
Gnomad ASJ exome
AF:
0.0101
Gnomad EAS exome
AF:
0.0000668
Gnomad FIN exome
AF:
0.00584
Gnomad NFE exome
AF:
0.0178
Gnomad OTH exome
AF:
0.0100
GnomAD4 exome
AF:
0.0151
AC:
21536
AN:
1426944
Hom.:
231
Cov.:
30
AF XY:
0.0147
AC XY:
10352
AN XY:
706320
show subpopulations
African (AFR)
AF:
0.00241
AC:
79
AN:
32808
American (AMR)
AF:
0.00515
AC:
206
AN:
39980
Ashkenazi Jewish (ASJ)
AF:
0.00903
AC:
230
AN:
25472
East Asian (EAS)
AF:
0.0000519
AC:
2
AN:
38556
South Asian (SAS)
AF:
0.000504
AC:
41
AN:
81322
European-Finnish (FIN)
AF:
0.00587
AC:
301
AN:
51282
Middle Eastern (MID)
AF:
0.00942
AC:
54
AN:
5732
European-Non Finnish (NFE)
AF:
0.0183
AC:
20033
AN:
1092630
Other (OTH)
AF:
0.00997
AC:
590
AN:
59162
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
995
1990
2985
3980
4975
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
748
1496
2244
2992
3740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0112
AC:
1713
AN:
152292
Hom.:
18
Cov.:
32
AF XY:
0.0103
AC XY:
767
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00277
AC:
115
AN:
41556
American (AMR)
AF:
0.00752
AC:
115
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0101
AC:
35
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00462
AC:
49
AN:
10606
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0194
AC:
1323
AN:
68024
Other (OTH)
AF:
0.00993
AC:
21
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
93
187
280
374
467
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0160
Hom.:
89
Bravo
AF:
0.0117
TwinsUK
AF:
0.0154
AC:
57
ALSPAC
AF:
0.0202
AC:
78
ESP6500AA
AF:
0.00329
AC:
12
ESP6500EA
AF:
0.0170
AC:
139
ExAC
AF:
0.00776
AC:
928
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Sep 13, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Severe combined immunodeficiency due to DNA-PKcs deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
15
DANN
Benign
0.64
DEOGEN2
Benign
0.15
T;.
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.59
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.83
T;T
MetaRNN
Benign
0.0031
T;T
MetaSVM
Benign
-1.1
T
PhyloP100
0.96
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-1.9
N;N
REVEL
Benign
0.031
Sift
Benign
0.33
T;T
Sift4G
Benign
0.30
T;T
Polyphen
0.0090
B;B
Vest4
0.079
MVP
0.58
MPC
0.17
ClinPred
0.0042
T
GERP RS
2.2
Varity_R
0.037
gMVP
0.25
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8178046; hg19: chr8-48841708; API